BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28696844)

  • 1. Comparison of MicroRNAs Mediated in Reactivation of the γ-Globin in β-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea.
    Hojjati MT; Azarkeivan A; Pourfathollah AA; Amirizadeh N
    Hemoglobin; 2017 Mar; 41(2):110-115. PubMed ID: 28696844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
    Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
    Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity.
    Pourfarzad F; von Lindern M; Azarkeivan A; Hou J; Kia SK; Esteghamat F; van Ijcken W; Philipsen S; Najmabadi H; Grosveld F
    Haematologica; 2013 May; 98(5):696-704. PubMed ID: 23100274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients.
    Watanapokasin Y; Chuncharunee S; Sanmund D; Kongnium W; Winichagoon P; Rodgers GP; Fucharoen S
    Exp Hematol; 2005 Dec; 33(12):1486-92. PubMed ID: 16338491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea.
    Chondrou V; Stavrou EF; Markopoulos G; Kouraklis-Symeonidis A; Fotopoulos V; Symeonidis A; Vlachaki E; Chalkia P; Patrinos GP; Papachatzopoulou A; Sgourou A
    Hum Genomics; 2018 Oct; 12(1):45. PubMed ID: 30285874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
    Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S
    Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.
    Chou YC; Chen RL; Lai ZS; Song JS; Chao YS; Shen CK
    Mol Cell Biol; 2015 Jul; 35(14):2541-53. PubMed ID: 25986606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
    Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
    Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells.
    Li H; Lin R; Li H; Ou R; Wang K; Lin J; Li C
    Hematology; 2022 Dec; 27(1):1152-1162. PubMed ID: 36178486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
    Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R
    Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia-Major Patients with the
    Ghosh D; Panja A; Saha D; Banerjee U; Datta AK; Basu A
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):563-570. PubMed ID: 34406845
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A.
    Lulli V; Romania P; Morsilli O; Cianciulli P; Gabbianelli M; Testa U; Giuliani A; Marziali G
    PLoS One; 2013; 8(4):e60436. PubMed ID: 23593217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
    Fucharoen S; Siritanaratkul N; Winichagoon P; Chowthaworn J; Siriboon W; Muangsup W; Chaicharoen S; Poolsup N; Chindavijak B; Pootrakul P; Piankijagum A; Schechter AN; Rodgers GP
    Blood; 1996 Feb; 87(3):887-92. PubMed ID: 8562958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of cis-trans interplay between DNA sequences 5' to the (G)gamma- and beta-globin genes among Hb F-Malta-I heterozygotes/homozygotes and beta-thalassemia homozygotes/compound heterozygotes, and the effects of hydroxyurea on the Hb F/F-erythrocyte; the need for large multicenter trials.
    Felice AE; Borg J; Pizzuto M; Cassar W; Galdies R; Wettinger SB; Pulis S; Hunter GJ; Caruana MR; Farrugia M; Scerri CA
    Hemoglobin; 2007; 31(2):279-88. PubMed ID: 17486512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in β-thalassemia.
    Wang F; Ling L; Yu D
    Am J Med Sci; 2021 Jul; 362(1):5-12. PubMed ID: 33600783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study.
    Kolliopoulou A; Siamoglou S; John A; Sgourou A; Kourakli A; Symeonidis A; Vlachaki E; Chalkia P; Theodoridou S; Ali BR; Katsila T; Patrinos GP; Papachatzopoulou A
    Hemoglobin; 2019 Jan; 43(1):27-33. PubMed ID: 31039620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with Hydroxyurea Leads to Fetal Hemoglobin Reactivation through
    Parsasefat M; Safarpour H; Nomiri S; Miri-Moghaddam E
    Hemoglobin; 2022 May; 46(3):153-159. PubMed ID: 35506261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients.
    Kargutkar N; Sawant-Mulay M; Hariharan P; Chandrakala S; Nadkarni A
    Sci Rep; 2023 Jan; 13(1):369. PubMed ID: 36611033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intrinsic genetic and epigenetic regulator factors as therapeutic targets, and the effect on fetal globin gene expression.
    Adelvand P; Hamid M; Sardari S
    Expert Rev Hematol; 2018 Jan; 11(1):71-81. PubMed ID: 29149573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.